momentum pt reiter
estim move also expect upward revis
street
believ result link demonstr abil take advantag
market opportun execut well across entir busi result
across board either met exceed strh street estim
beat driven acceler growth tech analyt
contract sale medic solut appear turn corner
strong book drive y/i backlog growth backlog burn
improv think well posit acceler organ growth
growth better growth faster saw acceler
deceler matter tech analyt organ cc growth
acceler trend first month
organ cc mark improv growth prior
year meanwhil saw deceler neg growth contract sale
 medic solut vs mid teen declin first month
appear turn corner stabil faster
expect direct posit think flat
growth year segment
margin better margin bigger margin may moder
quarter quarter may priorit up-front invest ahead recogn
revenu nevertheless expect year year advanc margin
recogn oper leverag time moreov manag
indic still remain overlap expens ims/quintil
merger suggest us cost synergi could continu
trickl reinforc margin expans opportun time
expect averag bp annual improv adj ebitda
estim move model less repurchas
limit upsid ep estim rais
revenu estim
respect ebitda margin remain unchang
higher revenu assumpt result adj ebitda
improv
respect ep estim improv
contempl strength real world busi
faster backlog burn associ pass-
revenu
turnaround appear arriv sooner
expect less repo given size recent repo
leverag higher share price
tr target
revenu depict prior year
adjust account rule
revenu prior reflect account
respect model worth repurchas
pt price target primarili reflect higher impli multipl
ep estim in-lin broad peer group averag
page
page
share upsid current strh factsetstrh scenariovaluationnot model scenario estim ep includ stock-bas comp compar peer match pro forma report ep pt low/high rangesourc factset strh research ia hold inc
page
sandi draper statement dollar y/i total gross depreci restructur merger impair oper fit incl restruc net interest expens incom incom incom tax tax equiti unconsolid equiti earn unconsolid net net loss incom attribut non-controlling net incom attribut dilut dilut share forma adjust net adj pre-tax tax non-gaap net non-gaap ep onward recast growth forma adjust ebitdaadjust ebitda onward recast margin robinson humphrey research estimatestick iqva
iqvia largest cro revenu oper countri employe
compani found headquart durham nc compani formerli quintil
merg im health combin entiti iqvia oper three segment commerci
solut data technolog drive real world evid use life sceinc client clinic
trial integr healthcar servic contract sale compris
respect sale iqvia first went public taken privat privat equiti
went public acquir im health
buy rate base view ebitda growth exceed revenu growth due
oper leverag cost synergi recognit expect manag reinforc oper
perform share repurchas expect contribut mid-teen ep growth
also think acquir im busi may benefit multipl expans mid-cap peer
technolog servic space given acquisit im
valuat risk
pt assign probabl low case price-to-earnings stock mid case
price-to-earnings stock high case price-to-earnings stock pt impli price-to-earnings
multipl ep estim in-lin peer averag ntm multipl
risk rate price target
continu cancel late stage busi net book bill remain target
merger synergi fail materi custom attrit due im merger
sandi draper herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
